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THE NEPHROTIC SYNDROME IN CHILDHOOD:
PROLONGED GLUCOCORTICOID THERAPYt
It is generally agreed that the addition of corticotropin and the glucocor-
ticoids to the therapy of the nephrotic syndrome has brought about a
significant reduction in the morbidity and mortality of this disorder,
although it is still too soon to be certain of the ultimate survival rate.`'
While many aspects of treatment with these medications have become
relatively standardized, opinions vary as to the optimum duration of
steroid treatment, and whether the tendency to prolong steroid adminis-
tration is justified by an improvement in prognosis. When first introduced,
cortisone and corticotropin were given in 5 to 16 day courses solely to
induce diuresis.`8 Subsequently Lange, et al.' noted that the frequency of
exacerbations could be appreciably reduced if the initial treatment was fol-
lowed by up to eight weeks of intermittent therapy (three consecutive
days each week). Cooke'0 proposed that the duration of treatment be as
long as 24 weeks, and Lange, et al.' in 1958 further extended the time
to 18 months. Others have felt, however, that such prolonged administration
is neither necessary nor advisable."
At this institution in recent years a policy had evolved of treating
children who had the nephrotic syndrome with high doses of glucocorticoids
for rather long periods of time. This was done because of a growing im-
pression that the long-term results of such therapy were superior to
those of comparatively limited treatment schedules, and vastly superior
to those obtained before the availability of steroids.
It was felt that a review of our experience was indicated not only to
confirm or deny the above impression but also to obtain a clearer picture
of the modifications which modern therapy have imposed upon the natural
history of the disorder since it was reviewed at this institution in 1949.'
* U.S. Public Health Service Trainee of the National Institute of Arthritis and
Metabolic Diseases.
**Associate Professor of Pediatrics.
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Such a retrospective study possesses the usual deficiencies expected when
reviewing a large group of patients seen over a number of years by different
physicians whose policies changed as experience was accumulated. On the
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FIG. 1. The relationship between the age at onset of the nephrotic syndrome and
the clinical status of 71 patients after treatment with corticotropin or a glucocorticoid.
The condition of each patient at the end of the study period was classified as follows:
I. Complete remission.
II. Clinically well with mild proteinuria (+ or ++).
III. Clinically well with severe proteinuria (+++ or ++++).
IV. Nephrotic syndrome, active.
V. Deceased.
other hand, it may provide a valuable guide in approaching similar prob-
lems in the future.
The present study indicates that glucocorticoid therapy has favorably
affectedtheprognosis in the nephrotic syndrome but that the results obtained
here with long-term administration do not appear to differ from those
obtained at other centers employing shorter treatment schedules.
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CASE MATERIAL
The 71 patients reviewed in this series developed the nephrotic syndrome when
they were under 16 years of age; they were both ward and private patients in the
Yale-New Haven Medical Center between September 1950 and September 1960,
and numbered 21 females (30%) and 50 males (70%). Among them were 65 Caucas-
ian, 3 Negro and 3 Puerto Rican children. The age distribution at the time of
onset is shown in Figure 1. The youngest patient was 10 months and the oldest 15¼2
years. Illness occurred in the majority after the age of one and before the age of six.
The highest incidence of the disorder was during the third year of life. Allergy was
present in 17 (24%) and diabetes developed in one patient.
TABLE 1. PRINCIPAL DIsoRDER PRECEDING OR ACCOMPANYING
THE ONSET OF NEPHROSIS IN 71 PATIENTS
No. cases
Upper respiratory infection 29
Otitis 3
Pneumonia 1
Gastroenteritis 2
Conjunctivitis 1
Meningitis 1
Mumps 1
Insect bite 1
Lead poisoning 1
None 31
Total 71
In three families (4%o) there were two siblings with nephrosis. In two of the
families, only one sibling was included in this series; in one a brother had prev-
iously recovered and in the other a brother had died of the disease prior to 1950.
Renal disease other than nephrosis (nephritis, pyelonephritis, nephrolithiasis or
renal carcinoma) was present in the families of 25 patients (32%). Diabetes was
present in 10 families (14%o) and allergy in 22 families (31%).
Two-thirds of the cases developed in the spring and fall (35% and 31% respectively),
while the remainder was divided equally between summer and winter.
The onset of the condition in 40 patients (56%) was preceded or accompanied by
another disorder, usually infectious in nature (see Table 1). A 3 cm. reaction to
an insect bite was noted five days prior to the onset of nephrosis in one patient.
In another, paint ingestion preceded the onset of nephrosis and lead encephalopathy by
one month.
The following laboratory determinations were performed: blood hematocrit, hemo-
globin and red and white cell and differential counts; intracutaneous PPD using
0.00001 mg.; urinalysis; intravenous pyelography; L.E. cell test; urine culture; blood
urea nitrogen or nonprotein nitrogen; and serum albumin, globulin, cholesterol, sodium,
potassium, chloride and total carbon dioxide.
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DIAGNOSTIC CRITERIA
The usual criteria used in making the diagnosis of nephrotic syndrome
are edema, proteinuria, hypoalbuminemia and hypercholesterolemia. As
noted in Table 2, 2 children had no edema, 3 had serum albumin values
greater than 3 g/100 ml and 6 had serum cholesterol values less than
280 mg/100 ml. All eventually demonstrated the complete syndrome,
however, except for two patients who responded rapidly to therapy and
have remainedwell since.
At least one manifestation of nephritis was present in 22 (31%o) patients
at onset. Hypertension, defined as an arterial blood pressure greater than
130/90 mm. Hg, was present in nine patients (12%o). Azotemia, a blood
urea nitrogen above 20 mg/100 ml or nonprotein nitrogen above 40
mg/100 ml, was present in 18 (25%o). Hematuria, the presence of three
or more red blood cells per high power field in the centrifuged sediment
of a casual specimen, was noted in 16 patients (23%o). Hypertension and
hematuria were present in one of these patients, azotemia and hematuria
in one, and all three signs of nephritis were present in three cases. If
more than one of these manifestations persisted after diuresis had been
achieved, the additional diagnosis of chronic nephritis was made and
glucocorticoid therapy was terminated.
A relapse was considered to have taken place if the patient developed
a moderate or heavy proteinuria which persisted more than about five
days or was initially accompanied by an elevation of the erythrocyte sedi-
mentation rate and a decrease in the serum albumin concentration.
MANAGEMENT
In general, the children were allowed to determine their own activity and
no dietary restrictions were imposed unless edema was pronounced. At such
times no salt was added during the preparation of food. Abdominocentesis
and thoracentesis were done only when the degree of discomfort merited
such treatment. In certain cases where edema was refractory to steroid
therapy (up to 60 mg. of prednisone per day) spironolactone (Aldactone®),
chlorothiazide (Diuril®) and supplementary potassium chloride were also
given. Confinement to the hospital was minimized.
At home the patients' urines were tested by the parents with sulfosalicylic
acid three times weekly. During acute illness the tests were done daily.
Antibiotics. Antibiotics were given along with steroid therapy. Prior to
1951, these were used only for the treatment of specific infection. Since
that time oral penicillin (200,000 to 600,000 units per day) or, more com-
monly, one of the tetracyclines (15 to 25 mg. per kilogram per day) has
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been employed for prophylaxis. This has been given until one year after
the termination of steroid therapy.
Glucocorticoid therapy. In the majority of cases treatment was begun
with ACTH (corticotropin) and then continued with a glucocorticoid. The
latter was initially given daily in four divided doses (continuous therapy),
m
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FIG. 2. The relationship between the length of time from onset of the nephrotic syn-
drome and the clinical status of 71 patients after treatment with corticotropin or a
glucocorticoid. For an explanation of symbols see Fig. 1. "I + steroid" indicates
that fraction of the patients who were category I and who were still receiving
glucocorticoid therapy at the time.
and after three to six months was given only on three or four consecutive
days each week or each two weeks (intermittent therapy). This was main-
tained until the urine had been protein-free for about three years.
Specific therapeutic regimens will be outlined in the next section.
RESULTS
The status of the group at the end of the 10 year period is indicated
in Figure 2. Twelve (18%f) were in complete remission 2 months to 9
years following the completion of therapy. Forty-three (60%o) were in
complete remission but were still receiving some form of glucocorticoid
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therapy. Three (4% ) were clinically well with mild proteinuria, one (1%o)
was clinically well with marked proteinuria, two (3%o) had the nephrotic
syndrome and 10 (14%o) had expired.
RESULTS OBTAINED WITH SPECIFIC THERPEUTIC PROGRAMS
I. Sixty of the 71 patients began treatment with ACTH, 75 to 100 mg. daily for
10 to 14 days, given usually in gelatin and intramuscularly.
A. One patient (P.R., Table 3) died in 1956 during the twelfth day of ACTH
therapy.
B. No subsequent glucocorticoid therapy was planned for eight children, but
all went on to relapse within 1 to 12 months and were then treated with
ACTH followed by intermittent therapy with 200 to 400 mg. of cortisone
three consecutive days each week, prior to 1954; or after that date with 30
to 40 mg. daily of prednisone, reduced gradually over 3 to 4 months to 10
to 25 mg., followed by intermittent prednisone at the determined dosage for
about three years.
One of these children (R. Br., Table 3) died in 1958 in the ninth year
of his disease, while receiving continuous prednisone therapy for his eighth
recurrence.
The remaining seven children were free of proteinuria and in complete re-
mission. In five of these patients steroid therapy had been discontinued from
2 to 9 years. The other two children were still receiving treatment.
C. In 22 of the patients the initial course of ACTH was immediately followed
by intermittent therapy with 200 to 400 mg. of cortisone or its equivalent of
hydrocortisone for three consecutive days each week for a period of 1 to
6 years.
Three patients died in uremia during or after this therapeutic program:
one (G.W.) in 1957, two years after the steroid therapy had been discon-
tinued because of severe hypertension and azotemia; and two (R.Ba.,
B.Mc.) in 1954 and 1955, while still receiving steroid therapy.
One patient treated from 1950 to 1954 developed diabetes while receiving
intermittent therapy eight months after the onset of nephrosis and seven
months after beginning therapy; he is now clinically well with persistent
mild proteinuria.
Another, who developed the disorder in 1954, became refractory to therapy
even though ACTH, cortisone and prednisone were variously employed.
Although at the conclusion of the study he continued to manifest the nephrotic
syndrome while still receiving prednisone, he was without clinical evidence of
nephritis.
Seventeen patients were in complete remission, and steroid had been discon-
tinued in five of these from 2 months to 4 years.
D. The initial course of ACTH was followed by continuous treatment with a
glucocorticoid in 29 patients.
1. Twenty-four received 30 to 60 mg. per day of prednisone which was reduced
over a 2 to 8 month period to 10 to 25 mg. per day; they then were given
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this reduced dosage for three or four consecutive days each week or each
two weeks (intermittent therapy) for 1Y2 to 6 years.
One child (L.A.) died in 1955 while on continuous prednisone during
the third week of therapy.
Another patient fulfilled the criteria for the diagnosis of chronic nephritis
in 1958 during the seventh month of continuous therapy, and therapy
was therefore discontinued; she continues to have mild proteinuria.
Twenty-two patients were in complete remission, but all were receiving
steroids at the conclusion of the study period.
2. Four received 100 to 400 mg. of cortisone per day for 3 months to 2 years
and were then maintained on intermittent therapy at the same dosage three
consecutive days each week for an additional 2 to 6 years. All in this
group were in complete remission at the end of the study period, and
all but one were still receiving steroid.
3. One patient received prednisolone daily starting at 10 mg. and increasing
to 30 mg. over four months. This was then discontinued because of per-
sistent, severe hypertension; the patient (C.Z.) died five months later
normotensive, but in uremia and with E. Coli sepsis.
II. Nine patients began treatment with prednisone, 30 to 60 mg. per day, between
1956 and 1960. After 10 to 31 days the dose was reduced gradually over a 1 to 4
month period, but continuous therapy was maintained for 3 to 9 months.
Two patients (K.F., D.T.) died during the initial, continuous therapy four
and five months, respectively, after the onset of treatment.
A third patient (J.M.) died in the second year of his disease. He had received
an additional course of continuous prednisone therapy for one month for treat-
ment of a relapse, but this was discontinued one month prior to death because
of lethargy, hypertension and azotemia. Following one week of therapy with
125 mg. daily of chlorothiazide, he expired with hypokalemia.
One patient had mild proteinuria after three months of continuous therapy.
Two months after the end of the study period, while still receiving continuous
therapy, she became free of proteinuria.
The single patient who was clinically well but had marked proteinuria per-
sisting after nine months of continuous therapy, was a 15 year old Caucasian
female whose renal tissue, obtained by percutaneous needle biopsy at that time,
demonstrated focal membranous glomerulonephritis. Otherwise, she had no clinical
manifestations of chronic nephritis and L.E. cell tests and studies for antinuclear
globulins were negative. Glucocorticoid therapy was then discontinued.
A 14 year old Negro female, who continued to manifest the nephrotic syndrome
after eight months of continuous therapy, was also without clinical evidence
of nephritis. Steroid therapy was discontinued after percutaneous renal biopsy
revealed generalized hyalinization and contraction of the glomeruli.
The remaining three patients were in complete remission while still receiving
steroid therapy.
III. In one patient, 200 mg. of cortisone for 14 days was used initially and followed
by intermittent cortisone therapy (three consecutive days each week of the same
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daily dose) for 3Y2 years. The patient was in complete remission three years
after discontinuation of steroid.
IV. One patient initially was given triamcinolone. Following a three week course
of 32 mg. per day, therapy was continued at a reduced daily dose (8 mg.) for
four months. This was followed up to the end of the study period by intermittent
prednisone at a dose of 20 mg. for four consecutive days each week for
two years. He was in complete remission at that time.
TABLE 3. CLINICAL AND HISTOLOGICAL FINDINGS IN 10 PATIENTS WHO
DIED DURING GLUCOCORTICOID THERAPY FOR NEPHROSIS
Age at
onset Duration of Clinical Histological
Patient (yrs) disease nephritis Cause of death nephritis*
R.Ba. 3 21 mo. yes Uremia, pulmonary edema
P.R. 1'/2 2y2 mo. yes Uremia, pulmonary edema yes
B.Mc. 1Y2 5Y4 yr. yes Uremia, pulmonary edema yes
J.M. 2 2 yr. no Uremia, pulmonary edema
and hypokalemia (1.7) yes
A.W. 3Y2 5 yr. yes Uremia, hyperkalemia (7.3) yes
L.A. 3/3 3 mo. yes Uremia, hyperkalemia (7.0),
E. coli sepsis, A.
aerogenes peritonitis no
C.Z. 1I/6 11 mo. no Uremia, E. coli sepsis yes
K.F. 11/12 5 mo. no Hyperkalemia (7.1) no
D.T. 5Y2 4y mo. yes Paracolon bacterium sepsis,
A. aerogenes peritonitis no
R.Br. 4 9 yr. ** Undetermined ...
* The presence of proliferative or membranous glomerulonephritis and fibrotic or
hyalinized glomeruli in samples of kidney obtained by biopsy or autopsy.
** The patient was receiving 20 mg. daily of prednisone. His serum NPN was 65 mg/100
ml, and his blood pressure 180/120 mm Hg the day before he died. Two weeks previously
his NPN was 40 mg/100 ml, and his blood pressure 140/100 mm Hg.
Ten children had failed to survive to the end of the study period (Table
3). Six of them were male (5 Caucasian and 1 Puerto Rican) and four
were female (3 Caucasian and 1 Puerto Rican). The duration of the
nephrotic syndrome was 2X2 months to 9 years. Five children died within
five months of onset; autopsy or renal biopsy revealed normal glomeruli
or thickening of the basement membrane in three, and proliferative
glomerulonephritis with occasional hyalinized glomeruli in two. The three
patients who manifested marked hematuria, hypertension and azotemia
266
Volume 35, December 1962Glucocorticoid therapy in nephrotic syndrome I GRYBOSKI, BRANDT
at onset were in this group. Two of these had histological evidence of
nephritis: one (P.R.) died during initial ACTH therapy and the other
(L.A.) during continuous therapy. The third (D.T.) died during the fourth
month of continuous therapy. The other five died more than one year
after the onset. Autopsy performed on three of them revealed proliferative
glomerulonephritis in one and membranous glomerulonephritis with a
predominance of hyalinized and contracted glomeruli in the others. Autopsy
TABLE 4. DURATION OF THE NEPHROTIC SYNDROME PRIOR TO STEROID THERAPY,
TIME REQUIRm FOR THERAPY TO BRING ABOUT REMISSION, AND CLINICAL
STATUS OF 71 PATIENTS AT END OF STUDY PERIOD
Classi- Time required for steroid
fication Duration of nephrotic syndrome therapy to bring
at end prior to therapy (weeks) aboutcompleteremission (weeks)
of study* 0-12 12-78 0-3 3-35 35 up
I 49 6 49 4 2
II 2 1 1 1 1
III 1 1
IV 1 1 1 1
V 10 4 1 5
Total no. 63 8 55 6 10
Mortality 16 0 7 17 50
(%)
X' re Insignificant Significant
mortality (P <.01)
* See legend of Figure 1.
was not performed on two patients. One of these fulfilled the criteria for
chronic nephritis three months prior to death and the second did so 24
hours prior to death.
There was no statistically significant difference in mortality rate between
patients treated prior to and after the disorder had been present for three
inonths (Table 4). The number of cases in the second category, however,
would appear to be too small to confirm any conclusion about the effect of
delay in instituting therapy upon the prognosis of the disorder.
The majority of patients in complete remission at the end of the survey
responded within the first three weeks of treatment. Mortality and mor-
bidity increased as the time required to respond extended beyond this
period (Table 4). In the 3-35 week category 5, 9, 11 and 20 weeks were
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required for the four patients who achieved Class I, and 7 weeks for
the one who achieved Class II. In the greater than 35 week category, 16
and 18 months of therapy were given to the two who achieved Class I
and 24months for the onein Class II.
No differences have been noted in the response to ACTH, cortisone or
prednisone. The apparently large proportion of deaths in the exclusively
prednisone-treated group was not statistically significant (p > .05).
RELAPSES
Twenty-four children had no relapses after demonstrating a rapid and
complete response to glucocorticoid therapy. Nine patients had not re-
sponded to therapy and five of these had expired by the end of the study
period.
Thirty-eight patients had a total of 102 relapses. Although this averaged
2.7 per relapsing patient, 12 had only one while 17 each had more than
three. One patient had 13. Fourteen children had 26 relapses during
continuous therapy. Half did so while receiving daily 20 mg. or less of
prednisone or 100 mg. or less of cortisone; they had remissions within two
weeks of increasing the steroid dose. The other 7 experienced relapses
while receiving more than 20 mg. of prednisone per day; at the end of the
study period only 2 were in complete remission, 1 had chronic nephritis,
.1 had the nephrotic syndrome, and 3 were dead.
Twenty-five children had 54 relapses while receiving intermittent
therapy; all but one of them responded to another course of therapy; one
patient died of undetermined causes while on treatment. No correlation
could be made between the age or steroid dose at the time of relapse and
the time required for the urine to become protein-free.
Fourteen children had 22 relapses from 2 weeks to 8 years after com-
pletion of steroid therapy. Another course of therapy brought about a
remission within two weeks in all instances but one, in which remission
did not take place until after two months of therapy.
Interestingly, five of the six children who were Class I and who required
more than 3 weeks of therapy to bring about the initial complete remission
(Table 4), had from one to five relapses; all cleared after less than 8
weeks of treatment, usually after less than 4 weeks.
Relapses were associated with a variety of events. Immunizations with
diphtheria-pertussis-tetanus, poliomyelitis vaccine and gamma globulin
were followed by relapse in 2 patients who had completed therapy and
in 3 patients free of proteinuria while on intermittent therapy. One child
suffered relapses twice when the steroid-free interval of his intermittent
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therapy schedule was extended beyond four consecutive days of the week.
Two relapses were precipitated in another child when prednisone was
sharply decreased to 5 mg. daily following exposures to varicella. Sunburn
and bee sting were thought to be responsible factors in two patients.
Fourteen patients had 39 exacerbations which were preceded by upper
respiratory infection and three had exacerbations preceded by viral enteritis;
all responded to continuous therapy, the majority within two weeks.
No antecedent factor could be determined for the remaining 49 relapses.
There have been 14 instances of transient proteinuria lasting up to five
days and associated with upper respiratory infections. These subsided
without alteration of therapy and were not included in the above data.
COMPLICATIONS OF THERAPY
Several patients demonstrated complications of continuous therapy. One
developed duodenal ulcer during the fourth month of continuous prednisone
therapy, five months prior to death from hypokalemia and uremia, and one
died during initial ACTH therapy and had multiple duodenal ulcerations
at autopsy. Guaiac-positive stools were noted in three after three weeks of
continuous prednisone therapy without radiologic evidence of ulceration in
the gastro-intestinal tract. In one of the three the melena subsided spontane-
ously. The other two responded quickly to demulcent therapy and discon-
tinuation of steroids. Pancreatitis was found at autopsy in the one patient
who died during the twelfth day of initial ACTH therapy.
There were no serious intercurrent infections with the exception of
the three cases noted in Table 3. Between 1950 and 1953 a clinical
diagnosis of peritonitis was made three additional times without verification
by culture. Five patients developed oral moniliasis which cleared promptly
with nystatin or amphotericin B therapy.
Papilledema was noted in three patients receiving continuous steroid
therapy; in all cases it subsided within five months even though the
steroid dose was not reduced in two of the cases. Two were receiving
30 mg. daily of prednisone, and one 12 mg. of triamcinolone. During
intermittent therapy with 15 mg. of prednisone, papilledema reappeared in
one patient. Two complained of headache and one experienced blurring of
vision. The blood pressure did not exceed 140/100 mm. Hg at the time
papilledema was noted.
Some degree of hyperglucocorticism developed in all patients during
initial and continuous therapy, but subsided as the dose of steroid was
decreased. Obesity, voracious appetite and marked lability of mood were
fairly characteristic. Hypertension developed during the course of therapy
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in 24 patients. In six it was severe, and five were treated with pentolinium
or reserpine. It subsided when steroid was decreased in all cases except
C. Z. and A. W. (Table 3), who died (still hypertensive) 6 and 23
months, respectively, after being taken off therapy. Osteoporosis was noted
in X-rays taken of children on continuous therapy for more than one
year. Two fractures occurred (one of a metatarsal and one of a humerus)
following minimal trauma. Growth failure was noted in four patients who
were still receiving steroid therapy at the conclusion of the study period.
All were in or below the third percentile for height and had received
steroid therapy for 3Y4 years or more with continuous therapy comprising
at least one-third of the total treatment time.
No complications of intermittent therapy were seen.
PROGNOSIS IN DECADE PRIOR TO STEROID THRAPY
Russell' has summarized the status of a group of 29 children with
the nephrotic syndrome studied at this institution in the decade ending
in 1948. At the end of the study period 3 (10%o) were in complete re-
mission 10 months to 8 years after onset. Three (10%o) were clinically
well with mild proteinuria 3 to 5.5 years after onset and 5 (17%o) were
clinically well with marked proteinuria after 2 months to 4.5 years. Eight
(28%o) still had the nephrotic syndrome 3 months to 3 years after onset,
and 10 (35%o) had died from 2 weeks to 2 years after onset.
DISCUSSION
No child included in the series had known renal disease prior to the
onset of the nephrotic syndrome. During the period of the study three
patients were seen on whom a diagnosis of chronic nephritis had been
made previously; they were excluded. The preponderance of males in this
study has also been noted by others," although this has not been a con-
sistent finding. The relatively few Negro and Puerto Rican children in this
series corresponds to the proportion of these groups in this area.
It is of interest that the onset of the illness was associated with infection
in 38 cases (54%o). Almost all of these were minor, nonbacterial upper
respiratory infections for which an etiological role in the nephrotic
syndrome can only be assumed (Table 1). Such an inference appears justi-
fied, since similar disorders appear to have been responsible for all
of the transient proteinurias as well as nearly one-third of the recurrences
ofthe full-blown nephrotic syndrome.
The incidence of familial renal disease other than the nephrotic syndrome
is significantly higher than that reported by Barnett,' and the incidence
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of allergy is similar to his figure and thus higher than in the general
population.
The 71 cases segregate into two groups on the basis of the relationship
between the age at onset of the disorder and the condition at the end
of the study period. In Figure 1 it will be noted that the 59 patients who
developed the nephrotic syndrome while under six years of age were either
well or else had not survived, while only one patient had a persistent
proteinuria. The latter had initially attained complete remission but had
developed diabetes in 1953. On the other hand, all 12 of those who
developed the disorder after six years of age had survived, although an
appreciable proportion (42%) had active nephrotic syndrome or persistent
proteinuria. Only one manifested chronic glomerulonephritis clinically,
while histological examination of biopsy specimens of kidney tissue in two
others demonstrated apicture consistent with such adiagnosis. This dissocia-
tion between the severity of the histological and clinical picture in some
patients has been noted by others."7"8 The older children appeared to follow a
pattern of response to therapy resembling that of the adult."' This suggests
that there may be either two or more basic disorders or an age specific
variation in the manifestations of a single basic disorder; it is also possible
that both factors may be involved. The uniformly fatal outcome in young
infants is pertinent to these speculations.'
The four children who had siblings with the nephrotic syndrome all
developed the disorder after the third year of life, responded to therapy
within 3 weeks, and were in complete remission 9 months to 9 years later.
This is contrary to the course of events in the "familial nephrosis"
described by Vernier in which the manifestations frequently appear earlier
inlifeand are more resistant totherapy.'
A relative paucity of serious infection was noted during the treatment
period. Indeed, while there was initially some concern about bringing
about antibiotic-resistant infection secondary to the prolonged administra-
tion of tetracyclines, no such problem developed. Several mild cases of
oral moniliasis were noted, but these responded rapidly to specific anti-
fungal therapy. Parents frequently commented that the children under
treatment not only had fewer respiratory infections than previously, but
also seemed to escape someofthefamily-wideepidemics.
A bacteriologically unconfirmed diagnosis of peritonitis was made in
3 patients, and infection contributed to 3 deaths. The bacteriological findings
of the latter are described in Table 3. This is in contrast to the occurrence
of infection at this center during the decade prior to the availability of
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steroid therapy and the use of prophylactic antibiotics.1' During that
period 28%o of patients with the nephrotic syndrome developed peritonitis,
30%o developed septicemia, and 29%o developed pneumonia one or more
times. Pneumococcus was the most frequently identified organism. With
the use of prophylactic antibiotics, infection by this organism has virtually
disappeared. Infection brought about 40%o of the deaths in the pre-steroid
decade at this institution and 30%o of the deaths in the present series.
All patients in both groups who died from infection did so within 11
months of their initial visit to the hospital. Coliform bacilli were cultured
firom all butonepatient.
The high number of relapses which were associated with upper res-
piratory infections, most likely viral in origin, may to some extent be at-
tributed to the relative lack of confinement and isolation precautions. It
was felt that since the majority of patients became clinically well the
advantages to both them and their families of leading a nearly normal life
seemed to outweigh the possible consequences of increased exposure to
infection.
Despite the frequent relapses, it was gratifying to note that most
children who did so while on low dosage continuous therapy or on inter-
mittent therapy, and all of those who did so after successful completion
of therapy, experienced a complete remission following an additional
course of full-dosage continuous glucocorticoid. Similar experiences have
been described by others.`" This suggests that the nephrotic syndrome is
a manifestation of some more fundamental process which, if not advanced
to an irreversible stage, can be more or less corrected, so that the effects
of repeated episodes are not cumulative.
Conversely, recurrences which appeared in children receiving high
dosage continuous therapy carried a poorprognosis.
The transient proteinurias associated with upper respiratory infections
cleared spontaneously without alteration of therapy and did not appear to
affect the over-all prognosis. Since these have been categorized only during
the last three years of the study it is possible that prior to that time some
children had been needlessly subjected to the resumption of full-dosage
continuous therapy at the first reappearance of proteinuria.
The relationship between the duration of therapy and the length of
time that the patients were free of proteinuria could not be evaluated be-
causeofthehigh recurrence rate.
In general a favorable outcome has been associated with a complete
response to therapy within 3 weeks (Table 4). The maintenance of com-
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plete remission for the ensuing 12 months, or rapid response to therapy
of exacerbations which occurred during that time have been associated
with a benign long-term course. Although McCrory, et al.2' have noted a
benign long-term course in patients who are in clinical remission 3 months
after the initiation of therapy, this has not been the experience in the
present study. The prospect for recovery was poor in those who did not
respond to therapy or who required more than 35 weeks of treatment to
bring about some degree of remission.
The length of time between the onset of the nephrotic syndrome and the
beginning of hormone therapy did not appear to affect the results (Table
4). Nor could a direct correlation be found between the length of time
from onset to therapy and the mortality rate. This is contrary to the con-
clusions reached in the reports of Heymann,' Lange,' and Piel' in which
the percentage of cures decreased and the percentage of deaths increased
with the duration of the disorder prior to therapy.
It is of interest to attempt to correlate specific findings present before
therapy with the condition of the patients at the conclusion of the study
(Table 2). The association of an appreciable degree of hematuria at
the time of onset of the nephrotic syndrome with a poor prognosis has
been frequently noted, both before6 and since' steroid therapy became
available. An increase in mortality rate associated with other manifestations
of nephritis (azotemia and hypertension) has been similarly noted prev-
iously.'3 In the present series, however, only the degree of edema and of
hypoalbuminemia and the concurrent association of hypertension, azotemia
and marked hematuria had a statistically significant effect on survival as
determined by the chi square method (Table 2). Barnett's group discussed
the poor correlation between the clinical picture at onset and the ultimate
prognosis.'
Azotemia or hematuria alone were not considered contraindications to
the use of glucocorticoid therapy, and the latter was initiated or main-
tained despite elevation of arterial pressure as high as 150/100 mm. Hg.
When a greater rise occurred, the medication was decreased in dosage or
discontinued.
The three patients who presented initially with azotemia, hematuria
and hypertension were all treated with continuous therapy for a period of
several months. Two began treatment with ACTH followed by prednisone,
but the third did not have the initial course of ACTH. Their deterioration
was a gradual phenomenon and did not appear to become accelerated
by therapy.
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While the glucocorticoid schedule in this series is comparable to that
employed by others (Table 5), none report the maintenance of therapy
beyond 18 months after the urine protein test has become negative. Since
other investigators have attained much the same results administering
steroids for as little as 28 days, there may not have been any advantage
in extending therapy beyond this time, particularly in those patients
who have had complete remissions within three weeks of initiation of
therapy and who have not had relapses. This question is an impossible
one to resolve in an uncontrolled retrospective study such as this; yet it
is important enough so that one would hope that properly controlled
prospective series will be accumulated.
Most authorities would agree, however, that patients who have not shown
a favorable early response would appear to benefit from a more prolonged
course of therapy individualized according to the degree and persistence
of their proteinuria. In support of this are the demonstrations by Galan
and Maso' and Worthen, et al."8 of improvement in the morphological
glomerular lesions during steroid therapy. One patient who had persistent
proteinuria has attained complete remission since completion of the survey
after five months of intensive continuous therapy. Although others8 " '
feel that there is no benefit in the prolongation of continuous therapy
beyond one month in the presence of proteinuria, the low number of
children with residual proteinuria in this series may imply an advantage
to prolonging it to as long as six months, employing a daily dose of
iup to 60 mg. of prednisone, followed by intermittent therapy for a maximum
of one year. However, it is not possible to state with certainty whether the
results so obtained in the relatively few cases who did not respond within
the first three weeks (Table 4) are distinguishable from those which
might be obtained in the same patients without the use of steroid therapy.
SUMMARY
Seventy-one patients with the nephrotic syndrome were treated with
prolonged glucocorticoid therapy during the decade ending in 1960. It
was found that the duration of the disorder prior to therapy did not affect
the long-term response, but that a more favorable outcome was associated
with a response to initial therapy within three weeks.
The presence of marked edema and hypoalbuminemia and the concurrence
of hypertension, azotemia and hematuria had a statistically significant as-
sociation with increased mortality. Failure to respond to therapy within
three weeks, and relapse into the nephrotic syndrome during vigorous
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continuous therapy was associated with a poor ultimate response to
therapy.
The results obtained by prolonging glucocorticoid therapy to more than
3 years in patients who had responded within 3 weeks and who had not
had early relapses did not appear to be any better than those obtained
by other workers who administered steroids for one month. Properly con-
trolled prospective studies are needed, however, in order to assess the
significance of this finding. Further prolonging the therapy may benefit
those who have not shown a favorable early response.
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